Carregant...

Comparison of in vivo Efficacy of Hypoxic Cytotoxin Tirapazamine and Hypoxic Cell Radiosensitizer KU‐2285 in Combination with Single and Fractionated Irradiation

Development of strategies to eradicate radioresistant hypoxic cells would be of great benefit for clinical radiotherapy. In the present study, the in vivo effects of a promising hypoxic cytotoxin, tirapazamine (3‐amino‐1,2,4‐benzotriazine 1,4‐di‐N‐oxide), were examined in comparison with those of KU...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Jpn J Cancer Res
Autors principals: Shibata, Toru, Shibamoto, Yuta, Sasai, Keisuke, Oya, Natsuo, Murata, Rumi, Takagi, Takehisa, Hiraoka, Masahiro, Abe, Mitsuyuki
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 1996
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5920986/
https://ncbi.nlm.nih.gov/pubmed/8609056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1996.tb00206.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!